Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Virginia F Borges

Showing results (111-120 of 139) with videos related to

Pageof 14
Sort By:
Frontiers in Oncology|November 30, 2019
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma PatientsRichard P Tobin, Kimberly R Jordan, Puja Kapoor, et al.
Elife|January 2, 2014
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancySvasti Haricharan, Jie Dong, Sarah Hein, et al.
Blood Advances|September 21, 2022
Patient perspectives on testing for clonal hematopoiesis of indeterminate potentialTal Sella, Geoffrey G Fell, Peter G Miller, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Breast Imaging During Pregnancy, Lonie R Salkowski, Alana A Lewin, et al.
Annals of Surgery|December 30, 2020
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort StudyHee Jeong Kim, Laura Dominici, Shoshana M Rosenberg, et al.
British Journal of Cancer|October 27, 2021
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancerYaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot studyHarold J Burstein, Lyndsay N Harris, Rebecca Gelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2022
Somatic and Germline Genomic Alterations in Very Young Women with Breast CancerAdrienne G Waks, Dewey Kim, Esha Jain, et al.
JCO Precision Oncology|June 26, 2023
Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Pageof 14

Showing results (111-120 of 139) with videos related to

Sort By:
Pageof 14
Frontiers in Oncology|November 30, 2019
IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma PatientsRichard P Tobin, Kimberly R Jordan, Puja Kapoor, et al.
Elife|January 2, 2014
Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancySvasti Haricharan, Jie Dong, Sarah Hein, et al.
Blood Advances|September 21, 2022
Patient perspectives on testing for clonal hematopoiesis of indeterminate potentialTal Sella, Geoffrey G Fell, Peter G Miller, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
Journal of the American College of Radiology : JACR|November 5, 2025
ACR Appropriateness Criteria® Breast Imaging During Pregnancy, Lonie R Salkowski, Alana A Lewin, et al.
Annals of Surgery|December 30, 2020
Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort StudyHee Jeong Kim, Laura Dominici, Shoshana M Rosenberg, et al.
British Journal of Cancer|October 27, 2021
Clinicopathological features and BRCA1 and BRCA2 mutation status in a prospective cohort of young women with breast cancerYaileen D Guzmán-Arocho, Shoshana M Rosenberg, Judy E Garber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot studyHarold J Burstein, Lyndsay N Harris, Rebecca Gelman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 2022
Somatic and Germline Genomic Alterations in Very Young Women with Breast CancerAdrienne G Waks, Dewey Kim, Esha Jain, et al.
JCO Precision Oncology|June 26, 2023
Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus TrastuzumabMarla Lipsyc-Sharf, Esha Jain, Laura C Collins, et al.
Pageof 14